Disease management produces limited quality-of-life improvements in patients with congestive heart failure: Evidence from a randomized trial in community-dwelling patients

Brad Smith, Emma Forkner, Barbara Zaslow, Richard A. Krasuski, Karl Stajduhar, Michael Kwan, Robert Ellis, Autumn D Galbreath, Gregory L. Freeman

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: Disease management programs are reported to improve clinical and quality-of-life outcomes while simultaneously lowering Healthcare costs. Objective: To examine the effectiveness of disease management in improving health-related quality of life (HRQL) among patients with heart failure beyond 12 months. Methods: A total of 1069 community-dwelling patients 18 years and older in South Texas with echocardiographic evidence of congestive heart failure were randomly assigned to disease management, augmented disease management, and control groups. They were followed up 18 months. Patients in the control group received usual care. Patients in the intervention groups were assigned a registered nurse as a disease manager who performed telephonic patient education and medication management. Health-related quality-of-life data (based on the Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36]) were collected 4 times, at 6-month intervals. Results: Disease management has a limited effect on HRQL. Analysis of the SF-36 health transition measure showed a positive effect of the intervention on self-reported improvement in health at 6 months and at 12 months (P = .04 and P = .004, respectively). However, no effect of disease management was observed across any of the SF-36 components. Women and patients with diastolic heart failure had poorer HRQL scores. Conclusions: Participation in disease management has little effect on HRQL outcomes in congestive heart failure. Beneficial effects on the SF-36 scale scores seen at 6 and 12 months were not sustained. Therefore, it is unclear whether disease management can provide long-term improvement in HRQL for patients with congestive heart failure.

Original languageEnglish (US)
Pages (from-to)701-713
Number of pages13
JournalAmerican Journal of Managed Care
Volume11
Issue number11
StatePublished - Nov 2005

Fingerprint

Independent Living
Disease Management
Quality Improvement
quality of life
Heart Failure
Quality of Life
Disease
health
management
community
evidence
Health Transition
Diastolic Heart Failure
Control Groups
Patient Education
Group
Health Surveys
Health Care Costs
Nurses
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Nursing(all)
  • Medicine(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Disease management produces limited quality-of-life improvements in patients with congestive heart failure : Evidence from a randomized trial in community-dwelling patients. / Smith, Brad; Forkner, Emma; Zaslow, Barbara; Krasuski, Richard A.; Stajduhar, Karl; Kwan, Michael; Ellis, Robert; Galbreath, Autumn D; Freeman, Gregory L.

In: American Journal of Managed Care, Vol. 11, No. 11, 11.2005, p. 701-713.

Research output: Contribution to journalArticle

Smith, B, Forkner, E, Zaslow, B, Krasuski, RA, Stajduhar, K, Kwan, M, Ellis, R, Galbreath, AD & Freeman, GL 2005, 'Disease management produces limited quality-of-life improvements in patients with congestive heart failure: Evidence from a randomized trial in community-dwelling patients', American Journal of Managed Care, vol. 11, no. 11, pp. 701-713.
Smith, Brad ; Forkner, Emma ; Zaslow, Barbara ; Krasuski, Richard A. ; Stajduhar, Karl ; Kwan, Michael ; Ellis, Robert ; Galbreath, Autumn D ; Freeman, Gregory L. / Disease management produces limited quality-of-life improvements in patients with congestive heart failure : Evidence from a randomized trial in community-dwelling patients. In: American Journal of Managed Care. 2005 ; Vol. 11, No. 11. pp. 701-713.
@article{83232398cebe4a6f99ab7c1d3cbdfc84,
title = "Disease management produces limited quality-of-life improvements in patients with congestive heart failure: Evidence from a randomized trial in community-dwelling patients",
abstract = "Background: Disease management programs are reported to improve clinical and quality-of-life outcomes while simultaneously lowering Healthcare costs. Objective: To examine the effectiveness of disease management in improving health-related quality of life (HRQL) among patients with heart failure beyond 12 months. Methods: A total of 1069 community-dwelling patients 18 years and older in South Texas with echocardiographic evidence of congestive heart failure were randomly assigned to disease management, augmented disease management, and control groups. They were followed up 18 months. Patients in the control group received usual care. Patients in the intervention groups were assigned a registered nurse as a disease manager who performed telephonic patient education and medication management. Health-related quality-of-life data (based on the Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36]) were collected 4 times, at 6-month intervals. Results: Disease management has a limited effect on HRQL. Analysis of the SF-36 health transition measure showed a positive effect of the intervention on self-reported improvement in health at 6 months and at 12 months (P = .04 and P = .004, respectively). However, no effect of disease management was observed across any of the SF-36 components. Women and patients with diastolic heart failure had poorer HRQL scores. Conclusions: Participation in disease management has little effect on HRQL outcomes in congestive heart failure. Beneficial effects on the SF-36 scale scores seen at 6 and 12 months were not sustained. Therefore, it is unclear whether disease management can provide long-term improvement in HRQL for patients with congestive heart failure.",
author = "Brad Smith and Emma Forkner and Barbara Zaslow and Krasuski, {Richard A.} and Karl Stajduhar and Michael Kwan and Robert Ellis and Galbreath, {Autumn D} and Freeman, {Gregory L.}",
year = "2005",
month = "11",
language = "English (US)",
volume = "11",
pages = "701--713",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "11",

}

TY - JOUR

T1 - Disease management produces limited quality-of-life improvements in patients with congestive heart failure

T2 - Evidence from a randomized trial in community-dwelling patients

AU - Smith, Brad

AU - Forkner, Emma

AU - Zaslow, Barbara

AU - Krasuski, Richard A.

AU - Stajduhar, Karl

AU - Kwan, Michael

AU - Ellis, Robert

AU - Galbreath, Autumn D

AU - Freeman, Gregory L.

PY - 2005/11

Y1 - 2005/11

N2 - Background: Disease management programs are reported to improve clinical and quality-of-life outcomes while simultaneously lowering Healthcare costs. Objective: To examine the effectiveness of disease management in improving health-related quality of life (HRQL) among patients with heart failure beyond 12 months. Methods: A total of 1069 community-dwelling patients 18 years and older in South Texas with echocardiographic evidence of congestive heart failure were randomly assigned to disease management, augmented disease management, and control groups. They were followed up 18 months. Patients in the control group received usual care. Patients in the intervention groups were assigned a registered nurse as a disease manager who performed telephonic patient education and medication management. Health-related quality-of-life data (based on the Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36]) were collected 4 times, at 6-month intervals. Results: Disease management has a limited effect on HRQL. Analysis of the SF-36 health transition measure showed a positive effect of the intervention on self-reported improvement in health at 6 months and at 12 months (P = .04 and P = .004, respectively). However, no effect of disease management was observed across any of the SF-36 components. Women and patients with diastolic heart failure had poorer HRQL scores. Conclusions: Participation in disease management has little effect on HRQL outcomes in congestive heart failure. Beneficial effects on the SF-36 scale scores seen at 6 and 12 months were not sustained. Therefore, it is unclear whether disease management can provide long-term improvement in HRQL for patients with congestive heart failure.

AB - Background: Disease management programs are reported to improve clinical and quality-of-life outcomes while simultaneously lowering Healthcare costs. Objective: To examine the effectiveness of disease management in improving health-related quality of life (HRQL) among patients with heart failure beyond 12 months. Methods: A total of 1069 community-dwelling patients 18 years and older in South Texas with echocardiographic evidence of congestive heart failure were randomly assigned to disease management, augmented disease management, and control groups. They were followed up 18 months. Patients in the control group received usual care. Patients in the intervention groups were assigned a registered nurse as a disease manager who performed telephonic patient education and medication management. Health-related quality-of-life data (based on the Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36]) were collected 4 times, at 6-month intervals. Results: Disease management has a limited effect on HRQL. Analysis of the SF-36 health transition measure showed a positive effect of the intervention on self-reported improvement in health at 6 months and at 12 months (P = .04 and P = .004, respectively). However, no effect of disease management was observed across any of the SF-36 components. Women and patients with diastolic heart failure had poorer HRQL scores. Conclusions: Participation in disease management has little effect on HRQL outcomes in congestive heart failure. Beneficial effects on the SF-36 scale scores seen at 6 and 12 months were not sustained. Therefore, it is unclear whether disease management can provide long-term improvement in HRQL for patients with congestive heart failure.

UR - http://www.scopus.com/inward/record.url?scp=27744535960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744535960&partnerID=8YFLogxK

M3 - Article

C2 - 16268753

AN - SCOPUS:27744535960

VL - 11

SP - 701

EP - 713

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 11

ER -